Brinzolamide CAS 138890-62-7

Khoom Piav Qhia

Khoom npe: Brinzolamide CAS TSIS: 138890-62-7

Txhais:

(R) - (+) - 4-ethylamino-2- (3-methoxypropyl) -3,4-dihydro-2H-thieno [3,2-e] -1,2-thiazine-6-sulfonamide -1,1-dioxide;

Birnzolamide;

Brinzolamide (BRZ);

3znc; Azopt; Azopt (TN);

(4R) -4- (ethylamino) -2- (3-methoxypropyl) -1,1-dioxo-3,4-dihydrothieno [3,2-e] thiazine-6-sulfonamide;

Tshuaj& Lub cev nqaij daim tawv

Zog: Dawb kom dawb-dawb hmoov

Ntsuas: ≥99.0%

Qhov ceev: 1.5 g / cm3

Lub Ntsiab Kub: 586 ℃ ntawm 760 mmHg

Melting Point: 130-134 ℃

Flash Point: 308.2 ℃

Brinzolamide (cov npe ua lag luam Azopt, Alcon Lub chaw soj nstuam, Befardin, Fardi Medicals,) yog carbonic anhydrase inhibitor siv los txo qis ntawm cov ntshav siab nyob hauv cov neeg mob nrog qhib lub ntsej muag glaucoma lossis ocular hypertension.

Brinzolamide tau qhia txog li Azopt hauv Asmeskas rau kev kho mob ntawm kev mob siab intraocular (IOP) hauv cov neeg mob ocular hypertension lossis openangle glaucoma. Brinzolamide yog cov ua rau muaj zog ntawm tib neeg carbonic anhydrase Ⅱ txo qis IOP tom qab kev tswj hwm tshuaj. Nws yog tus thib ob ntawm hoob no tom qab dorzolamide (1995). Brinzolamide tuaj yeem npaj hauv yim-qib los ntawm 3-acetyl-2,5-dichlorothiophene. Hauv cov neeg mob uas ua rau lub ntsej muag qhib lub ntsej muag lossis lub siab o tuaj, brinzolamide ua rau txo qhov tseem ceeb hauv IOP thiab pom tias tsis muaj kev phom sij ntau dua li dorzolamide.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.

Cim npe nrov: brinzolamide cas 138890-62-7, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag

• Tug: (S) - 3, 4-Dihydro-4-hydroxy-2 - (3 - methoxypropyl) -2H-thieno [3, 2-e] -1,2-thiazine -6-sulfonamide 1, 1-dioxide CAS 1 54127-42-1
• Tom ntej: Dorzolamide HCl CAS TSIS TAU: 130693-82-2